Garuda Therapeutics logo

Garuda Therapeutics Funding & Investors

Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.

garudatx.com

Total Amount Raised: $134,000,000

Garuda Therapeutics Funding Rounds

  • Series B

    $62,000,000

    Series B Investors

    Aisling Capital
    Cormorant Asset Management
    Northpond Ventures
    OrbiMed
    Mass General Brigham Ventures
    Sectoral Asset Management
    Alexandria Venture Investments
  • Series A

    $72,000,000

    Series A Investors

    Aisling Capital
    Northpond Ventures
    OrbiMed
    Cormorant Asset Management
    Monashee Investment Management
    Sectoral Asset Management
    Ridgeback Capital
    Mass General Brigham Ventures
    Resilience
Funding info provided by Diffbot.